| 17-AAG | 17-Allylamino-17-demethoxygeldanamycin |
| 17-DMAG | 17-Desmethoxy-17-N,N-dimethylaminoethyl amino geldanamycin |
| AKT | Protein kinase B |
| APC | Antigen-presenting cell |
| ATP | Adenosine triphosphate |
| BRAF | v-raf murine sarcoma viral oncogene homolog B1 |
| BSDL | Bile-salt-dependent lipase |
| CHOP | C/EBP homologous protein |
| CR | Charged linker region |
| CRC | Colorectal cancer |
| CTD | C-terminal domain |
| EGFR | Epidermal growth factor receptor |
| ER | Endoplasmic reticulum |
| ERK | Extracellular signal-regulated kinase |
| ER-α36 | Estrogen receptor-α36 |
| FAK | Focal adhesion kinase |
| GARP | Glycoprotein A repetitions predominant |
| GDA | Geldanamycin |
| GRP94 | Glucose-regulated protein 94 |
| GP | Glycoprotein |
| HCC | Hepatocellular carcinoma |
| HER2 | Human epidermal growth factor receptor 2 |
| HSP90 | Heat shock protein 90 |
| HSP90B1 | Heat shock protein 90 kDa beta member 1 |
| IGFs | Insulin-like growth factors |
| IgG | Immunoglobulin G |
| LRP6 | Lipoprotein receptor-related protein 6 |
| KRAS | Kirsten rat sarcoma 2 viral oncogene homolog |
| mAbs | Monoclonal antibodies |
| MD | Middle domain |
| NECA | 5′-N-ethylcarboxamidoadenosine |
| NTD | N-terminal domain |
| PD-1 | Programmed cell death protein-1 |
| PD-L1 | Programmed death-ligand 1 |
| PI3KCA | Phosphoinositide-3-kinase catalytic subunit alpha |
| PTEN | Phosphatase and tensin homolog |
| RDA | Radamide |
| RDC | Radicicol |
| scFv | Single-chain variable fragment |
| shRNA | Short hairpin RNA |
| TLRs | Toll-like receptors |
| TRA1 | Tumor rejection antigen 1 |
| uPAR | Urokinase-type plasminogen activator receptor |
| USFDA | The United States Food and Drug Administration |
| VEGF-A | Vascular endothelial growth factor-A |